These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 6882618)
1. Skeletal muscle digoxin binding in patients with renal failure. Jogestrand T; Ericsson F Br J Clin Pharmacol; 1983 Jul; 16(1):109-11. PubMed ID: 6882618 [TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle digoxin concentration and its relation to serum digoxin concentration and cardiac effect in healthy man. Jogestrand T; Sundqvist K Eur J Clin Pharmacol; 1981 Jan; 19(2):89-95. PubMed ID: 7202476 [TBL] [Abstract][Full Text] [Related]
3. Skeletal muscle digoxin concentration during digitalization and during withdrawal of digoxin treatment. Jogestrand T; Ericsson F; Sundqvist K Eur J Clin Pharmacol; 1981 Jan; 19(2):97-105. PubMed ID: 7202477 [TBL] [Abstract][Full Text] [Related]
4. [Elimination kinetics and dosage of digoxin in patients in renal failure (author's transl)]. Ohnhaus EE; Spring P; Dettli L Dtsch Med Wochenschr; 1974 Sep; 99(37):1797-803. PubMed ID: 4457307 [No Abstract] [Full Text] [Related]
5. Effect of digoxin upon intracellular potassium in man. Ericsson F; Carlmark B; Jogestrand T; Sundqvist K Scand J Clin Lab Invest; 1981 Sep; 41(5):457-63. PubMed ID: 7313528 [TBL] [Abstract][Full Text] [Related]
6. Skeletal muscle binding and renal excretion of digoxin in man. Schenck-Gustafsson K; Jogestrand T; Dahlqvist R Eur J Clin Pharmacol; 1987; 31(5):601-3. PubMed ID: 3830246 [TBL] [Abstract][Full Text] [Related]
7. Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm. Jogestrand T Eur J Clin Pharmacol; 1980 Apr; 17(4):243-50. PubMed ID: 7398729 [TBL] [Abstract][Full Text] [Related]
9. [Letter: Kinetics of elimination and dosage of digoxin in patients with kidney failure]. Risler T Dtsch Med Wochenschr; 1974 Oct; 99(42):2130-1. PubMed ID: 4426236 [No Abstract] [Full Text] [Related]
10. [Use of MDRD equation to detect occult renal failure and reduce the risk of digitalis overdose]. Cepeda Piorno J; Pobes Martínez de Salinas A; González García ME; Fernández Rodríguez E Nefrologia; 2009; 29(2):150-5. PubMed ID: 19396321 [TBL] [Abstract][Full Text] [Related]
13. Myocardial and skeletal muscle concentrations of digoxin in patients on long-term therapy. Coltart J; Howard M; Chamberlain D Br Med J; 1972 May; 2(5809):318-9. PubMed ID: 4623290 [TBL] [Abstract][Full Text] [Related]
14. Digoxin in the elderly and in renal failure. Contribution of erythrocyte 86-rubidium uptake tests. Zannad F; Royer RJ; Issartel G; Robert J Eur J Cardiol; 1981; 12(5):285-96. PubMed ID: 6265220 [TBL] [Abstract][Full Text] [Related]
16. Effect of salbutamol on digoxin concentration in serum and skeletal muscle. Edner M; Jogestrand T Eur J Clin Pharmacol; 1989; 36(3):235-8. PubMed ID: 2744063 [TBL] [Abstract][Full Text] [Related]
17. Quinidine-induced changes in serum and skeletal muscle digoxin concentration; evidence of saturable binding of digoxin to skeletal muscle. Jogestrand T; Schenck-Gustafsson K; Nordlander R; Dahlqvist R Eur J Clin Pharmacol; 1984; 27(5):571-5. PubMed ID: 6519162 [TBL] [Abstract][Full Text] [Related]
18. [Possible mechanisms of polyuria in progressive chronic renal failure]. Natochin IuV; Bogolepova AE Ter Arkh; 2000; 72(6):15-20. PubMed ID: 10900642 [TBL] [Abstract][Full Text] [Related]
19. Decreased volume of distribution of digoxin in a patient with renal failure. Szefler SJ; Jusko WJ Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1095-8. PubMed ID: 4760884 [No Abstract] [Full Text] [Related]
20. Myocardial distribution of digoxin and renal function. Jusko WJ; Weintraub M Clin Pharmacol Ther; 1974 Sep; 16(3):449-54. PubMed ID: 4414761 [No Abstract] [Full Text] [Related] [Next] [New Search]